Premix containing iron sucrose for raising pigs

Abstract

The invention relates to a premix containing iron sucrose for raising pigs, wherein the premix comprises the following components in parts by weight: 1-15 parts of cuprum, 20-50 parts of iron sucrose, 1-15 parts of zinc, 5-15 parts of manganese, 2-3 parts of iodine, 3-60 parts of calcium, 1- 4 parts of VA, 3-10 parts of VD3, 2-8 parts of VE, 5-8 parts of VK3, 3-9 parts of VB 1, 12-30 parts of VB2, 20-60 parts of pantothenic acid and 60-90 parts of nicotinic acid; the cuprum, the iron sucrose, the zinc, the manganese, the iodine and the calcium are stone powders; the VA, the VD3, the VE, the VK3, the VB1, the VB2, the pantothenic acid and the nicotinic acid are bran shell powders; and the premix provided by the invention can be obtained by mixing the stone powders and the bran shell powders in any proportion. The invention has the advantages of simple manufacturing process and lower cost; the survival rate of piglets can be effectively improved and the nutritional ingredients of the piglets are more balanced; and the premix containing iron sucrose for raising pigs has higher security and stability.

Description

technical field [0001] The invention belongs to the field of premix in animal husbandry, in particular to a pig premix containing iron sucrose. Background technique [0002] The purpose of the premix for pigs is mainly to supplement the lack of nutrients in the basic ration, so that the ration can reach the balance of nutrients, that is, the full price; there are also premixes for pigs that can enhance the body’s immunity, promote growth, and improve economic benefits. ;After years of research in the feeding process of piglets, the intake of iron is very important. Iron is a trace element necessary for the body and an essential component for the body to synthesize hemoglobin. According to statistics, about 30% of piglets Death is caused by iron deficiency. If iron is not supplemented in time, it will also bring the following unfavorable factors to piglets: (1) cannot form hemoglobin, myoglobin, cytochrome and various peroxidases, thereby affecting Delivery of nutrients in t...

AI Technical Summary

Problems solved by technology

[0002] The purpose of the premix for pigs is mainly to supplement the lack of nutrients in the basic ration, so that the ration can reach the balance of nutrients, that is, the full price; there are also premixes for pigs that can enhance the body’s immunity, promote growth, and improve economic benefits. ;After years of research in the feeding process of piglets, the intake of iron is very important. Iron is a trace element necessary for the body and an essential component for the body to synthesize hemoglobin. According to statistics, about 30% of piglets Death is caused by iron deficiency. If iron is not supplemented in time, it will also bring the following unfavorable factors to piglets: (1) cannot form hemoglobin, myoglobin, cytochrome and various peroxidases, thereby affecting Delivery of nutrients in the body; (2) low hemoglobin content, low oxygen carrying and oxygen supply capacity, which can easily cause organ failure; (3) increased incidence of diarrhea, edema, white muscle disease, etc., slow growth, rough and disordered back hair, Pale skin and mucous membranes, loss of appetite; (4) Decreased physiological function, low immunity, susceptibility to infection and secondary diseases

Iron dextran, which is currently used clinically in piglets, is mainly iron dextran. Although this drug can be effective in treating iron deficiency anemia in piglets, it has the following problems for long-term application: the synthesis of iron dextran is a very complicated process, and trivalent It is prepared by the complexation reaction between iron hydroxide and dextran molecules. The complexation reaction is very unstable and is affected by the pH value of the reaction system and FeCl 3 The concentration of the solution has a great influence, the product yield is low, the quality is poor, and the raw material cost of dextran is high, resulting in high prices of finished drugs, affecting clinical application